Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,030.00
Bid: 9,026.00
Ask: 9,032.00
Change: -34.00 (-0.38%)
Spread: 6.00 (0.066%)
Open: 9,082.00
High: 9,098.00
Low: 8,994.00
Prev. Close: 9,064.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

1 May 2019 07:00

RNS Number : 6522X
Next PLC
01 May 2019
 

Date:

Embargoed until 07.00hrs, Wednesday 1 May 2019

 

 

Contacts:

Amanda James, Group Finance Director (analyst calls)

 

NEXT PLC

Tel: 0333 777 8888

 

 

 

Alistair Mackinnon-Musson

Email: next@rowbellpr.com

 

Rowbell PR

Tel: 020 7717 5239

 

 

Photographs:

http://www.nextplc.co.uk/media/image-gallery/campaign-images

 

Next plc

Trading Statement - 1 May 2019

FIRST QUARTER SALES PERFORMANCE TO 27 APRIL 2019

Full price sales in the thirteen weeks to Saturday 27 April were up +4.5% on last year. This was +1.3% ahead of our internal forecast of +3.2% for the first quarter. We believe this over performance versus forecast was mainly as a result of unusually warm weather over the Easter holiday period, which was particularly helpful to our Retail stores. The table below sets out the full price sales performance for Retail, Online and Finance interest income. 

Full price sales (VAT exclusive)

13 weeks to

27 April

Retail

- 3.6%

Online

+11.8%

Product full price sales

+4.0%

Finance interest income

+11.4%

Total full price sales including interest income

+4.5%

Of which sales from new space

+0.3%

 

The graph below sets out the full price sales variance to last year by month. As expected, we experienced strong sales growth during February because sales were adversely affected by extreme winter weather last year. March was broadly in line with our forecast for the full year and, as mentioned above, sales during April were better than expected.

 

Click or paste the following link into your web browser to view the graph titled '2019 Full Price Sales Variance by Month vs 2018 (£m and %)'. Refer to page 1 for this graph. http://www.rns-pdf.londonstockexchange.com/rns/6522X_1-2019-4-30.pdf

FULL PRICE SALES AND PROFIT GUIDANCE FOR THE FULL YEAR

We do not currently believe that the over performance of the first quarter can be extrapolated through to the rest of the year. The over performance in the first quarter amounted to sales of around £10m. Given this is a relatively small number in the context of annual sales, we believe it is too early to revise our full year sales and profit guidance. For completeness, our central guidance is set out in the table below.

 

Full year estimate to January 2020

Central guidance

Retail sales (including sales from new space) versus 2018/19

- 8.5%

Online sales versus 2018/19

+11.0%

Finance interest income versus 2018/19

+9.9%

Total full price sales versus 2018/19

+1.7%

Group profit before tax1

£715m

Group profit before tax versus 2018/19

- 1.1%

Earnings Per Share growth versus 2018/192

+3.4%

 

1 This profit estimate excludes the impact of the transition to IFRS 16 'Leases'. 

2 We have assumed that £250m shares are repurchased in the first half of the year and a further £50m in the second half of the year, with a future share purchase price of £58.38, being the closing share price at 29 April 2019.

Note on expected sales phasing for the rest of the year

We think it would be helpful to reiterate the guidance we gave in our March presentation for the phasing of sales across the full year. This is not straightforward because last year the first quarter suffered extreme weather disruption from the "Beast from the East" and the second quarter benefitted from an unusually warm spring and summer. Predicting sales by quarter can only be very approximate but gives an indication of the expected sales phasing. With that caveat, the table below sets out our expectations by quarter for the rest of the year.

%

Q1 (actual)

Q2 (e)

Q3 (e)

Q4 (e)

Full price sales growth versus 2018/19

+4.5%

- 0.5%

+1.7%

+1.7%

CASH FLOW, SHARE BUYBACKS AND EPS

At our central guidance we estimate surplus cash3 generation of around £300m. As outlined in our January 2019 Trading Statement, we intend to return this £300m surplus cash to shareholders by way of share buybacks. We have purchased £86m to date.

As a result of the recent rise in our share price we now expect the enhancement from share buybacks to be 0.2% less than the 4.9% we initially expected. So, growth in Earnings Per Share, based on our central guidance for the full year, is now expected to be 3.4% rather than the guidance given in January of 3.6%.

3 Surplus cash is cash flow after capital expenditure, interest, tax and ordinary dividends but before financing any increase in Online debtors.

NEXT TRADING STATEMENT

Our next sales update will cover the first 26 weeks of the year, to 27 July 2019, and is scheduled for Wednesday 31 July 2019.

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVBLFXKZFBBBX
Date   Source Headline
1st May 20249:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTrading Statement
29th Apr 20244:30 pmRNSDirector/PCA Shareholding
26th Apr 20246:12 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:31 pmRNSHolding(s) in Company
12th Apr 20242:16 pmRNSAnnual Financial Report
8th Apr 20244:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20249:50 amRNSHolding(s) in Company
22nd Mar 20242:26 pmRNSDirector/PDMR Shareholding
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.